Modeling Dose-Response Microarray Data in Early Drug Development Experiments Using R Order-Restricted Analysis of Microarray Data

This book focuses on the analysis of dose-response microarray data in pharmaceutical setting, the goal being to cover this important topic for early drug development and to provide user-friendly R packages that can be used to analyze dose-response microarray data. It is intended for biostatisticians...

Full description

Bibliographic Details
Other Authors: Lin, Dan (Editor), Shkedy, Ziv (Editor), Yekutieli, Daniel (Editor), Amaratunga, Dhammika (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 2012, 2012
Edition:1st ed. 2012
Series:Use R!
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 03713nmm a2200409 u 4500
001 EB000387816
003 EBX01000000000000000240868
005 00000000000000.0
007 cr|||||||||||||||||||||
008 130626 ||| eng
020 |a 9783642240072 
100 1 |a Lin, Dan  |e [editor] 
245 0 0 |a Modeling Dose-Response Microarray Data in Early Drug Development Experiments Using R  |h Elektronische Ressource  |b Order-Restricted Analysis of Microarray Data  |c edited by Dan Lin, Ziv Shkedy, Daniel Yekutieli, Dhammika Amaratunga, Luc Bijnens 
250 |a 1st ed. 2012 
260 |a Berlin, Heidelberg  |b Springer Berlin Heidelberg  |c 2012, 2012 
300 |a XV, 282 p. 96 illus., 4 illus. in color  |b online resource 
505 0 |a Introduction -- Part I: Dose-response Modeling: An Introduction -- Estimation Under Order Restrictions -- The Likelihood Ratio Test -- Part II: Dose-response Microarray Experiments -- Functional Genomic Dose-response Experiments -- Adjustment for Multiplicity -- Test for Trend -- Order Restricted Bisclusters -- Classification of Trends in Dose-response Microarray Experiments Using Information Theory Selection Methods -- Multiple Contrast Test -- Confidence Intervals for the Selected Parameters -- Case Study Using GUI in R: Gene Expression Analysis After Acute Treatment With Antipsychotics 
653 |a Pharmaceutical chemistry 
653 |a Bioinformatics 
653 |a Computational and Systems Biology 
653 |a Statistics  
653 |a Biostatistics 
653 |a Pharmaceutics 
653 |a Statistics 
653 |a Mathematical statistics / Data processing 
653 |a Statistics and Computing 
653 |a Biometry 
700 1 |a Shkedy, Ziv  |e [editor] 
700 1 |a Yekutieli, Daniel  |e [editor] 
700 1 |a Amaratunga, Dhammika  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a Use R! 
028 5 0 |a 10.1007/978-3-642-24007-2 
856 4 0 |u https://doi.org/10.1007/978-3-642-24007-2?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 519.5 
520 |a This book focuses on the analysis of dose-response microarray data in pharmaceutical setting, the goal being to cover this important topic for early drug development and to provide user-friendly R packages that can be used to analyze dose-response microarray data. It is intended for biostatisticians and bioinformaticians in the pharmaceutical industry, biologists, and biostatistics/bioinformatics graduate students. Part I of the book is an introduction, in which we discuss the dose-response setting and the problem of estimating normal means under order restrictions. In particular, we discuss the pooled-adjacent-violator (PAV) algorithm and isotonic regression, as well as the likelihood ratio test and non-linear parametric models, which are used in the second part of the book.  Part II is the core of the book. Methodological topics discussed include: ·         Multiplicity adjustment ·         Test statistics and testing procedures for the analysis of dose-response microarray data ·         Resampling-based inference and use of the SAM method at the presence of small-variance genes in the data ·         Identification and classification of dose-response curve shapes ·         Clustering of order restricted (but not necessarily monotone) dose-response profiles ·         Hierarchical Bayesian models and non-linear models for dose-response microarray data ·         Multiple contrast tests All methodological issues in the book are illustrated using four “real-world” examples of dose-response microarray datasets from early drug development experiments